Back

Polyamine dysregulation converges with RASopathies on RAS/MAPK and sensory processing phenotypes in Drosophila

van Reijmersdal, B.; de Wit, M.; Prins, K.; Govers, Z. A.; Schreurs, P.; Boon, M.; Been, M.; Jones, S. G.; Schenck, A.

2026-01-24 genetics
10.64898/2026.01.23.701032 bioRxiv
Show abstract

RASopathies are developmental conditions associated with cognitive and sensory processing impairments. They are caused by pathogenic variants in genes that result in overactivation of the RAS/MAPK signaling pathway. Genes linked to this pathway have been reported to be enriched among Drosophila models with habituation deficits, a behavioral phenotype reflecting sensory filtering. To identify hidden RASopathies - monogenic disorders that converge on RAS/MAPK overactivation without being classically linked to the pathway - we generated 89 and screened 41 viable habituation-deficient Drosophila RNAi models for RAS/MAPK overactivation, measured as an increased phosphorylated ERK to ERK ratio. This screen identified Sms, the ortholog of human spermine synthase (SMS), implicated in Snyder-Robinson syndrome. RAS/MAPK overactivation along with hyperreactivity and habituation impairments are confirmed in a full loss-of-function mutant. A RNAi screen targeting polyamine pathway genes identified Sat (human SAT1/2, SATL1) to reproduce these phenotypes. Knockdown of Sms or Sat in GABAergic neurons impaired habituation, implicating polyamine metabolism in inhibitory circuit function. These findings reveal previously unrecognized convergence between polyamine dysregulation and RASopathies, suggesting shared therapeutic opportunities through modulation of either pathway. SUMMARY STATEMENTUsing Drosophila, we uncovered polyamine metabolism genes, Sms and Sat, as modulators of RAS/MAPK and sensory processing, revealing a shared mechanism between polyaminopathies and RASopathies that may inform unified therapies.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Genetics
756 papers in training set
Top 1%
10.1%
2
Genetics in Medicine
69 papers in training set
Top 0.2%
8.4%
3
Neurobiology of Disease
134 papers in training set
Top 0.6%
8.2%
4
Human Molecular Genetics
130 papers in training set
Top 0.3%
6.8%
5
The American Journal of Human Genetics
206 papers in training set
Top 0.7%
6.8%
6
Disease Models & Mechanisms
119 papers in training set
Top 0.3%
4.9%
7
Scientific Reports
3102 papers in training set
Top 31%
4.0%
8
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.1%
3.6%
50% of probability mass above
9
Translational Psychiatry
219 papers in training set
Top 2%
3.6%
10
Molecular Psychiatry
242 papers in training set
Top 1%
2.9%
11
Genes, Brain and Behavior
29 papers in training set
Top 0.1%
2.7%
12
GENETICS
189 papers in training set
Top 0.4%
2.6%
13
PLOS ONE
4510 papers in training set
Top 45%
2.6%
14
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.1%
2.1%
15
eLife
5422 papers in training set
Top 38%
1.9%
16
Biological Psychiatry
119 papers in training set
Top 2%
1.3%
17
Communications Biology
886 papers in training set
Top 14%
1.2%
18
Movement Disorders
62 papers in training set
Top 0.8%
1.1%
19
Sleep
26 papers in training set
Top 0.4%
1.0%
20
Cell Reports
1338 papers in training set
Top 30%
0.9%
21
American Journal of Psychiatry
20 papers in training set
Top 0.4%
0.8%
22
npj Parkinson's Disease
89 papers in training set
Top 1%
0.7%
23
Frontiers in Genetics
197 papers in training set
Top 10%
0.7%
24
Annals of Clinical and Translational Neurology
29 papers in training set
Top 1%
0.7%
25
Neuroscience
88 papers in training set
Top 3%
0.6%
26
Neurology
44 papers in training set
Top 2%
0.6%
27
Genetics
225 papers in training set
Top 5%
0.6%
28
Human Genetics and Genomics Advances
70 papers in training set
Top 1%
0.6%
29
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 47%
0.6%